Insight Public Affairs
We are an award winning 15-strong team of consultants able to offer extensive experience in politics, government, media and stakeholder engagement, across a breadth of policy areas including telecoms, technology, gambling, life sciences, financial services, housing, infrastructure, copyright, employment, media and advertising, food and drink, social care, retail, and education. As an independent agency we go that extra mile to deliver results-focussed communications strategies and programmes that fulfil our clients’ commercial imperatives. Working tirelessly to meet our clients’ goals, we are a team who understand client challenges, develop bespoke strategies and programmes, and meet these strategic objectives.
This is a FREE LISTING on PMHUB
Below are full profiles from other companies in related areas
Visions4Health
Visions4Health are market access experts and your gateway to local adoption at pace. Leveraging our lived experience, understanding of national and local healthcare systems, and insights generated by our stakeholder…
Company Details
Latest Content from PMHub
The value: why localisation pays off across global trials
White Papers and Resources | June 26, 2026 | Cuttsy + Cuttsy
Strong localisation reduces trial friction, supports site teams, improves participant understanding and helps global studies run more smoothly, fairly and efficiently.
Genesis Research Group launches free access to EVID AI, its full-spectrum evidence synthesis platform, through 2026
Press Releases | June 24, 2026 | Genesis Research Group
Genesis Research Group today announced that its EVID AI evidence synthesis platform will be available free of charge through 2026 for approved life sciences organizations and eligible researchers. “Run it...
Medscape Education to Showcase the Impact of Neurology CME at EAN 2026
Press Releases | June 23, 2026 | Medscape Education
Medscape Education, the leading global provider of continuing medical education (CME), has announced its agenda for the upcoming 12th Congress of the European Academy of Neurology (EAN) 2026 in Geneva,...
Designing Pharma Stands That People Actually Want to Step Onto
Press Releases | June 18, 2026 | Apex Events and Exhibitions
Exhibition halls are busy environments where delegates move quickly, often with limited time. For pharmaceutical companies, this presents a challenge: how do you create a stand that invites meaningful engagement...
Webcast | Smarter science, sharper strategy: Expert perspectives from ASCO® 2026
White Papers and Resources | June 18, 2026 | Inizio
Key insights from ASCO® 2026, including oncology trends, scientific highlights, and strategies for smarter congress engagement.
The solution: Good localisation doesn’t feel translated
White Papers and Resources | June 18, 2026 | Cuttsy + Cuttsy
Learn what good localisation looks like in clinical trials and why participant-facing materials should feel naturally relevant, culturally appropriate and easy to understand across every market.
Good Patient Partnership Guide 2026: Patient Journey Mapping with the Patient Community
White Papers and Resources | June 18, 2026 | Precision AQ
Patient insight gathering and journey mapping can inform and enhance decision making and initiatives across life sciences. The Good Patient Partnership Guide 2026 brings together practical guidance, real world examples...
Healthcare information is becoming easier to access. Trust isn’t.
White Papers and Resources | June 17, 2026 | Cuttsy + Cuttsy
Sharing key insights from NEXT Pharma Summit on why trust, clarity and human-centred communication matter more than ever in healthcare.
It was never reluctance: What ASCO 2026 revealed about clinical trial recruitment
White Papers and Resources | June 17, 2026 | Cuttsy + Cuttsy
ASCO 2026 highlighted that low clinical trial recruitment is driven less by patient reluctance and more by gaps in awareness, communication, accessibility and patient education.
J‑Pharma Co., Ltd. and Uniphar Announce Advancement of Nanvuranlat into Phase 3 Clinical Development Following FDA Alignment and Initial Patient Enrollment
Press Releases | June 17, 2026 | Uniphar
Strategic partnership enables direct progression to Phase 3, bypassing additional Phase 2 study, as first patients are randomized in global trial TOKYO, Japan and DUBLIN, Ireland — [June 16, 2026] J‑Pharma Co., Ltd., a clinical-stage biotechnology...